Clin Mol Hepatol.
2019 Mar;25(1):37-39. 10.3350/cmh.2018.1011.
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
- Affiliations
-
- 1Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju, Korea.
- 2Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea. baiksk@yonsei.ac.kr
- KMID: 2447248
- DOI: http://doi.org/10.3350/cmh.2018.1011
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Clinical Impact of AST-Platelet Ratio Index for Non-invasive Hepatic Fibrosis in the Patients with Chronic Hepatitis B
- Clinical Application of Non-invasive Diagnosis for Hepatic Fibrosis
- Evaluation of liver scanning image in various hepatic disease
- Differential Diagnosis of Diffuse Liver Disease
- Hepatic Iron and Copper Concentrations in Patients with Chronic Viral Hepatitis
